Does Comorbid Food Allergy Affect Response to Omalizumab in Patients with Asthma?
Department
Allergy and Immunology
Document Type
Article
Publication Title
Journal of Asthma and Allergy
Abstract
BACKGROUND: The intrinsic link between food allergy and asthma is well-established, and comorbidity can exacerbate both conditions. Omalizumab, an anti-immunoglobulin E (IgE) antibody, has the biological plausibility to manage both conditions, but only a few small studies have assessed omalizumab in patients with comorbid asthma and food allergy.
PATIENTS AND METHODS: We conducted a post hoc analysis of placebo-controlled, randomized clinical trials (IA05 in children and 008/009 in adolescents/adults) and real-world observational studies (EXCELS and PROSPERO). For each study, patients with asthma were stratified by whether they had physician-reported food allergy, as per baseline characteristics data.
RESULTS: For patients with comorbid food allergy, there was evidence for increased atopy at baseline (numerically higher total IgE levels and atopic comorbidities). The collective body of evidence found that omalizumab consistently improved general and asthma-specific patient-centered outcomes (food allergy-specific outcomes were not available). For patients with asthma, omalizumab improved healthcare resource use (emergency room visits, hospitalizations, unscheduled doctor visits), quality of life (asthma-specific Asthma Quality of Life Questionnaire), productivity (missed work/school days and the Work Productivity and Activity Impairment: Asthma), and asthma outcomes (asthma exacerbations and Asthma Control Test score) regardless of comorbid food allergy.
CONCLUSION: There was no loss of omalizumab efficacy even though patients with both asthma and food allergy appeared to be generally more atopic. Omalizumab may be a viable management option for patients with these comorbidities.
CLINICAL TRIAL REGISTRATION: NCT00079937; NCT01922037; NCT00252135.
First Page
889
Last Page
900
DOI
10.2147/JAA.S475517
Volume
17
Publication Date
9-1-2024
PubMed ID
39309477
Recommended Citation
Fiocchi, A., Chinthrajah, R. S., Ansotegui, I. J., Sriaroon, P., Mustafa, S. S., Raut, P., Cameron, B., Gupta, S., & Fleischer, D. M. (2024). Does Comorbid Food Allergy Affect Response to Omalizumab in Patients with Asthma?. Journal of Asthma and Allergy, 17, 889-900. https://doi.org/10.2147/JAA.S475517